Pulmodyne
IN - IndianapolisBiotechnology
Focus: Pulmodyne is a early-stage biotechnology company focused on disposable emergency airway products, headquartered in Indianapolis. Founded in 2022, the company operates in a specialized medical device niche within the broader biotech ecosystem.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Pulmodyne
AI assessmentNot HiringNo open roles listed right now. Follow Pulmodyne to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
CPAP mask system
Pre-Commercial
Early-stage disposable airway product in development phase with one ongoing trial; not yet commercialized or revenue-generating.
Pipeline & Clinical Trials
CPAP mask system
Continuous Positive Airway PressureHelp build intelligence for Pulmodyne
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.